$260 Million is the total value of Wildcat Capital Management, LLC's 30 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RLX | RLX TECHNOLOGY INCsponsored ads | $32,438,000 | -50.7% | 30,893,022 | 0.0% | 12.46% | -42.8% | |
CSGP | COSTAR GROUP INC | $28,256,000 | +15.3% | 405,685 | 0.0% | 10.86% | +33.8% | |
ALLO | ALLOGENE THERAPEUTICS INC | $22,986,000 | -5.3% | 2,128,370 | 0.0% | 8.83% | +9.9% | |
SKLZ | SKILLZ INC | $22,065,000 | -17.7% | 21,632,157 | 0.0% | 8.48% | -4.6% | |
TDG | TRANSDIGM GROUP INC | $18,562,000 | -2.2% | 35,368 | 0.0% | 7.13% | +13.4% | |
FYBR | FRONTIER COMMUNICATIONS PARE | $16,999,000 | -0.5% | 725,525 | 0.0% | 6.53% | +15.4% | |
CPNG | COUPANG INCcl a | $14,333,000 | +30.7% | 859,817 | 0.0% | 5.51% | +51.7% | |
GSHD | GOOSEHEAD INS INC | $12,712,000 | -22.0% | 356,683 | 0.0% | 4.88% | -9.5% | |
CNSL | CONSOLIDATED COMM HLDGS INC | $12,160,000 | -40.6% | 2,923,123 | 0.0% | 4.67% | -31.1% | |
GPN | GLOBAL PMTS INC | $8,638,000 | -2.3% | 79,941 | 0.0% | 3.32% | +13.3% | |
KRON | KRONOS BIO INC | $4,818,000 | -8.0% | 1,438,232 | 0.0% | 1.85% | +6.7% | |
URGN | UROGEN PHARMA LTD | $4,436,000 | +1.6% | 533,139 | 0.0% | 1.70% | +17.9% | |
NERDY INC | $1,156,000 | -0.9% | 547,800 | 0.0% | 0.44% | +14.7% | ||
DDOG | DATADOG INC | $864,000 | -6.8% | 9,731 | 0.0% | 0.33% | +8.1% | |
VACASA INC | $307,000 | +6.6% | 100,000 | 0.0% | 0.12% | +24.2% | ||
DOCN | DIGITALOCEAN HLDGS INC | $239,000 | -12.5% | 6,597 | 0.0% | 0.09% | +2.2% | |
OYST | OYSTER PT PHARMA INC | $207,000 | +29.4% | 36,847 | 0.0% | 0.08% | +50.9% | |
ROBINHOOD MKTS INC | $140,000 | +22.8% | 13,876 | 0.0% | 0.05% | +42.1% | ||
NERDY INC*w exp 08/16/202 | $40,000 | +33.3% | 99,600 | 0.0% | 0.02% | +50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-08
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
NANTKWEST INC | 17 | Q3 2019 | 22.0% |
SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-04-08 |
SC 13G | 2024-04-08 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-09 |
PX14A6G | 2023-11-03 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-07 |
SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.